IRIS UniCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 379
EU - Europa 366
AS - Asia 249
SA - Sud America 81
AF - Africa 6
Totale 1.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 368
IT - Italia 98
SG - Singapore 97
CN - Cina 74
BR - Brasile 66
SE - Svezia 58
DE - Germania 54
FR - Francia 42
IE - Irlanda 29
ID - Indonesia 23
KR - Corea 22
FI - Finlandia 20
GB - Regno Unito 16
UA - Ucraina 14
IN - India 10
CA - Canada 8
CO - Colombia 8
RU - Federazione Russa 7
BE - Belgio 6
HK - Hong Kong 5
AR - Argentina 4
CZ - Repubblica Ceca 4
ES - Italia 4
AT - Austria 3
NL - Olanda 3
TR - Turchia 3
UZ - Uzbekistan 3
EC - Ecuador 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IQ - Iraq 1
JM - Giamaica 1
LI - Liechtenstein 1
MA - Marocco 1
NG - Nigeria 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.081
Salva come PNG Salva come JPEG
Città #
Chandler 97
Singapore 78
Ashburn 32
Dublin 27
New York 24
Milan 23
Jakarta 22
Seoul 22
Hefei 17
Frankfurt am Main 15
Helsinki 13
Marseille 13
Rome 13
Los Angeles 11
The Dalles 10
Munich 9
Bogotá 8
Beijing 7
Nuremberg 7
Paris 7
Princeton 7
Pune 7
Boardman 6
Boston 6
Brussels 6
Jacksonville 6
North Bergen 6
Fairfield 5
Hong Kong 5
Houston 5
Portsmouth 5
Seattle 5
Appignano 4
Madrid 4
Moscow 4
Redwood City 4
Wilmington 4
Ann Arbor 3
Belo Horizonte 3
Brooklyn 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Düsseldorf 3
Hyderabad 3
Lauterbourg 3
London 3
Monte Argentario 3
San Diego 3
San Francisco 3
San Mateo 3
Toronto 3
Turku 3
Verona 3
Washington 3
Bremen 2
Brno 2
Busto Arsizio 2
Cattolica 2
Changsha 2
Chicago 2
Edinburgh 2
Falkenstein 2
Florence 2
Hangzhou 2
Jiaxing 2
Las Vegas 2
Lawrence 2
Montreal 2
Nanjing 2
Ospitaletto 2
Palhoça 2
Pescara 2
Saint-Fons 2
San Giovanni in Persiceto 2
Santa Clara 2
Stockholm 2
São Paulo 2
Tashkent 2
Abidjan 1
Abu Dhabi 1
Alexandria 1
Algiers 1
Andover 1
Antakya 1
Aracaju 1
Araçatuba 1
Arezzo 1
Arzachena 1
Augusta 1
Austin 1
Baghdad 1
Barbacena 1
Barão de Cocais 1
Belize City 1
Betim 1
Boksburg 1
Braço do Norte 1
Brdo 1
Bucharest 1
Totale 667
Salva come PNG Salva come JPEG
Nome #
Effect of moderate and heavy alcohol consumption on intestinal transit time 96
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 94
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 91
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 72
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 69
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 68
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 52
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 51
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 50
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 48
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 38
Microbiota Composition in Diverticular Disease: Implications for Therapy 38
Microbiota Composition in Diverticular Disease: Implications for Therapy 38
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 38
Response to Jackson et al 38
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 35
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 27
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 27
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 25
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 25
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 25
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 24
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 21
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 14
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 6
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 2
Totale 1.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 0 3
2020/202123 0 2 7 3 3 1 1 0 2 0 3 1
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025464 13 10 45 20 46 13 21 19 46 77 139 15
Totale 1.112